ADO 4.76% 2.2¢ anteotech ltd

go go ... ado

  1. 83 Posts.
    Summary
    ? Mix&Go? is a proven and commercialised technology
    ? Mix&Go? now targeting an established IVD (pathology) market
    ? Mix&Go? being tested by healthcare companies in multiple sectors - pathology
    (IVD), research, point of care, diagnostics, immunoprecipitation, R&D
    ? Over 60 leading healthcare companies currently testing and assessing the
    technology ? not one has said no
    ? Mix&Go? has multiple applications outside of healthcare
    ? ADO well funded with $7.0 million in cash ? potential to access current market
    opportunities with current cash position



    Short term value drivers
    Research & Development: Currently 2-3 healthcare R&D companies actively
    considering Mix&Go? - short term revenue
    opportunities as R&D companies take less time on
    approval processes
    Major global IVD Players: ADO is currently working on supply agreements
    with leading global IVD players
    Life sciences market: ADO actively pursuing possible supply agreement
    with leading global life sciences company
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.001(4.76%)
Mkt cap ! $54.30M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $1.433K 65.12K

Buyers (Bids)

No. Vol. Price($)
4 742031 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 457092 5
View Market Depth
Last trade - 15.31pm 23/07/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.